About this trial
This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults ≥18 years of age
Undergoing double lung transplantation via bilateral thoracotomies or clamshell incision
Disqualifiers
Multi-organ transplant recipients
Redo lung transplant recipients
Trial design
Parallel
Treatments tested in this trial
Atricure CryoSPHERE MAX Probe
DevicePatients will be treated intra-operatively with Atricure CryoSPHERE MAX Probe to 2 intercostal spaces above and below the thoracotomy incision for 1 minutes for each application during their double lung transplant procedure.
Treatment groups
Trial outcomes
Primary outcomes
Total opioid use (oral morphine equivalents)
Total opioid use (oral morphine equivalents)
Secondary outcomes
Frequency of rescue therapy
Compare need for thoracic epidural anesthesia.
Median daily pain score
To compare the Median daily pain score for the first 10 days after lung transplantation, Numerical Rating Scale (NRS) (0-10): A standard 11-point scale (0=no pain, 10=worst imaginable pain) used for pain intensity, showing good reliability and validity in various conditions like neuropathic pain.
Duration of ICU Stay
To compare the duration of the ICU stay
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, Los Angeles
Lead sponsor
AtriCure, Inc.
Collaborator